A, B., K, F., G, G., M, R., C, M., P, C., & E, B. (2026). Lipid excipients as key modulators of the apparent intestinal permeability in lipid-based formulations: Insights from Caco-2 and Caco-2/HT29-MTX models. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 223, 115055. https://doi.org/10.1016/j.ejpb.2026.115055
Παραπομπή σε μορφή Chicago (17η εκδ.)A, Bourderi-Cambon, Fadhlaoui K, Garrait G, Rossano M, Miolane C, Caisse P, και Beyssac E. "Lipid Excipients as Key Modulators of the Apparent Intestinal Permeability in Lipid-based Formulations: Insights from Caco-2 and Caco-2/HT29-MTX Models." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V 223 (2026): 115055. https://doi.org/10.1016/j.ejpb.2026.115055.
Παραπομπή σε μορφή MLA (9th εκδ.)A, Bourderi-Cambon, et al. "Lipid Excipients as Key Modulators of the Apparent Intestinal Permeability in Lipid-based Formulations: Insights from Caco-2 and Caco-2/HT29-MTX Models." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V, vol. 223, 2026, p. 115055, https://doi.org/10.1016/j.ejpb.2026.115055.